EuBiologics Signs 13.3 Billion Won Cholera Vaccine Supply Deal with UNICEF
On June 5, EuBiologics announced that it had signed a contract with UNICEF to supply oral cholera vaccines worth 13.3 billion won.
The contract amount accounts for 8.89% of the company’s sales in the previous year. The product to be supplied is EuVICOL, and the contracting party is the international organization UNICEF.
EuBiologics continues to supply cholera vaccines, focusing on the public procurement market. This contract also involves a volume secured in the international procurement market, where demand for vaccines to respond to infectious diseases remains strong.
Hot Picks Today
"1.4 Million Won for a Family of Four: This City Grants 350,000 Won Per Person Ahead of Chuseok"
- "Why Hire Employees? Earning 14 Billion Alone... Number of Single-Person Companies Doubled in Two Years"
- "Everyone Was Traveling Abroad"... Why Did Travel Agencies' Operating Profits Plunge by 40%?
- It Was Like Buying a New Car and Sending It to the Junkyard... Kim Wonhoon's Total SK Hynix Buy: At What Price Did He Invest?
- "Fears of Severe Cases Rising"... COVID-19 Positive Rate Soars to 20%, but Treatments Remain Out of Reach in China
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
